Skip to main content
Indivior PLC logo

Indivior PLC — Investor Relations & Filings

Ticker · INDV ISIN · GB00BN4HT335 LEI · 213800V3NCQTY7IED471 IL Manufacturing
Filings indexed 1,983 across all filing types
Latest filing 2025-02-04 Regulatory Filings
Country GB United Kingdom
Listing IL INDV

About Indivior PLC

https://www.indivior.com/en

Indivior PLC is a global pharmaceutical company that develops, manufactures, and sells medicines to treat substance use disorders (SUD) and serious mental illnesses. The company's primary focus is on pioneering treatments for opioid use disorder (OUD), with a portfolio centered on buprenorphine-based prescription pharmaceuticals. Through its research and development efforts, Indivior aims to address the complex challenges of addiction and behavioral health by providing innovative, life-transforming therapies for patients worldwide.

Recent filings

Filing Released Lang Actions
TRANSACTION IN OWN SHARES
Regulatory Filings
2025-02-04 English
Notice of Results
Report Publication Announcement Classification · 99% confidence The document is a short announcement (6279 characters) released via RNS (Regulatory News Service) by Indivior PLC. The core content is an announcement stating that the company 'will release its Q4 / FY 2024 results on February 20th' and will host a webcast presentation. It does not contain the actual financial results or the full report itself. According to Rule 2, when a document announces the publication of a report and provides links/details for accessing that future event or report, it should be classified as a Report Publication Announcement (RPA). The presence of the RNS Number and the closing statement about RNS confirms its nature as a regulatory announcement.
2025-02-04 English
Completion of Share Repurchase Program
Transaction in Own Shares Classification · 100% confidence The document is an official announcement from Indivior PLC regarding the completion of a share repurchase program. It details the total number of shares purchased, the total consideration paid, and the average price per share. This falls under the category of a company buying back its own shares, which is specifically defined as 'Transaction in Own Shares' (POS).
2025-02-04 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states it is a 'WEEKLY REPORT' concerning the 'SHARE REPURCHASE PROGRAM' of Indivior PLC. It details the number of ordinary shares purchased for cancellation during a specific period (Jan 27, 2025, to Jan 31, 2025) and provides aggregated transaction data. This activity directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase). The RNS number and the reference to FCA regulations confirm it is a regulatory disclosure, but the specific subject matter points directly to the POS code.
2025-02-04 English
TOTAL VOTING RIGHTS
Regulatory Filings
2025-02-03 English
APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR
Regulatory Filings
2025-02-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.